Skip to Content

User Reviews for Norinyl 1+35

The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.

Reviews for Norinyl 1+35

For Acne "It works very well for acne and birth control."

10

E.N.T <3 February 3, 2009

25 users found this comment helpful.
Did you? Yes No | Report inappropriate

More about Norinyl 1+35 (ethinyl estradiol / norethindrone)

Consumer resources

Norinyl 1+35 birth control

Other brands: Lo Loestrin Fe, Taytulla, Junel Fe 1/20, Microgestin Fe 1/20, ... +42 more

Professional resources

Norethindrone, Ethinyl Estradiol and Ferrous Fumarate (FDA)

Related treatment guides

Birth Control

Drug Status

Rx

Availability Prescription only

Pregnancy & Lactation Risk data available

CSA Schedule* Not a controlled drug

Drug Class

Contraceptives
Sex hormone combinations

Related Drugs

Birth Control medroxyprogesterone, Depo-Provera, Provera, Mirena, norethindrone, Yaz, levonorgestrel, Sprintec, Nexplanon, Ortho Tri-Cyclen, Lo Loestrin Fe, NuvaRing, Yasmin, TriNessa, Alesse, Taytulla, Tri-Sprintec, Aviane, Junel Fe 1 / 20, Estarylla, ParaGard, Xulane, Apri, Aygestin, Gianvi, More...

Norinyl 1+35 Images

Pill Imprint SYNTEX (Norinyl 1+35 inert)

Norinyl 1+35 inert (SYNTEX)

Get Email Updates

Subscribe to free Drugs.com newsletters.

By clicking Subscribe, I agree to the Drugs.com Terms & Conditions and Privacy Policy and understand that I may opt out of Drugs.com subscriptions at any time.

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include IBM Watson Micromedex (updated Jan 9th, 2019), Cerner Multum™ (updated Jan 14th, 2019), Wolters Kluwer™ (updated Jan 7th, 2019) and others. To view content sources and attributions, please refer to our editorial policy.